pharmaceutical grade bpc-157 BPC 157 trifluoroacetate BPC‑157 Research Peptide | Genetra

This regulatory status reflects the absence of completed human clinical trials establishing safety and efficacy to approval standards

BPC-157 related signaling has been associated with nitric oxide mediated cascades involving Src, Cav-1, and eNOS signaling components [1]

Although it entered phase I clinical trials in this regard, BPC-157 is not certified by the US Food and Drug Administration (FDA) for medical use

The formation of ice crystals during the freeze-thaw cycle can physically shred the delicate peptide chains, destroying the compound just as effectively as heat

Using non-sterile equipment undermines the bacteriostatic protection